Has Michael Liston, MD received payments from drug or device companies?

Yes. Drug and device makers reported $112,593 in general payments to Michael Liston, MD across 616 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Liston, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Liston, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Liston, MD

Cardiovascular Disease · Blue Springs, MONPI 1093735557

Payments from drug & device makers

$112,593in general payments, 2019–2025

Across 616 payments — averaging $182.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi US Services Inc.$38K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$38K
Lexicon Pharmaceuticals, Inc.$19K
Biotronik Inc.$9K
Novartis$1K
Amgen$1K
plus $6K from 36 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi US Services Inc.	5	$38,091
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	30	$38,081
Lexicon Pharmaceuticals, Inc.	3	$18,706
Biotronik Inc.	121	$9,078
Novartis	100	$1,264
Amgen	60	$1,200
Johnson & Johnson	42	$835
E.r. Squibb & Sons, L.L.C.	36	$727
Merck	28	$615
Pfizer	37	$567
AstraZeneca	23	$420
Boehringer Ingelheim	18	$393
Sanofi-aventis U.S. LLC	22	$384
Boston Scientific	17	$344
Alnylam Pharmaceuticals Inc.	10	$307
Medtronic(3 entities)	8	$272
Shockwave Medical, Inc	6	$211
Abbott	6	$210
Irhythm Technologies, Inc.	5	$125
Regeneron Healthcare Solutions, Inc.	4	$86
Esperion Therapeutics, Inc.	4	$80
Kiniksa Pharmaceuticals International, PLC	4	$72
Amarin Pharma, Inc.	3	$60
Kiniksa Pharmaceuticals, Ltd.	2	$49
Kestra Medical Technology Services, Inc.	1	$47
Bayer	2	$45
Scpharmaceuticals Inc.	2	$38
Sanofi	1	$28
Medicomp Inc	1	$27
Gilead	2	$24
Teleflex LLC	1	$24
Kowa Pharmaceuticals America, Inc.	2	$23
Osprey Medical Inc	1	$20
Vifor Pharma, Inc.	1	$19
Penumbra, Inc.	1	$18
GSK	1	$16
Infobionic, Inc	1	$16
Philips North America LLC	1	$15
Cardiva Medical, Inc.	1	$14
Amryt Pharma Holdings Ltd	1	$14
Atricure, Inc.	1	$14
Arbor Pharmaceuticals, Inc.	1	$13

How this compares

$112,593 in reported general payments places this provider in the 90th percentile of 391 cardiovascular disease providers in Missouri.

See all cardiovascular disease providers in Missouri →

Medicare billing

Part B allowed, 2024

$212,646

Medicare patients

907

Services billed

2,937

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Blue Springs

David BlickBlue Springs$133K
Mikhail KosiborodKansas City$27.8M
Mohammad TahirSaint Louis$2.7M
John SpertusKansas City$2.3M
Joshua MitchellSaint Louis$1.4M
Nathan StitzielSaint Louis$1.2M
Daniel KellySaint Louis$1.1M
Georges ChahoudSaint Louis$967K
Jiafu OuSaint Louis$853K
William BowenSaint Louis$726K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →